News summary

Brain methylation accounted for 8.6% of APOE's link to Alzheimer's

Source: Longevity Docs News • Published: 13 Oct 2026, 00:00

Summarized by Masters of Longevity from Longevity Docs News.

This medical-news article previews a postmortem research study examining brain DNA methylation’s role in linking APOE genotype to Alzheimer’s risk, inviting readers curious about molecular contributors to dementia.

Brain methylation accounted for 8.6% of APOE's link to Alzheimer's
Key Takeaways
  • The study analyzed dorsolateral prefrontal cortex from 1,250 deceased participants from five Rush cohorts and found 107 methylation sites associated with Alzheimer’s pathology.
  • Thirty-eight of the 107 methylation sites replicated in independent analyses.
  • DNA methylation in the prefrontal cortex accounted for 8.6% of the association between APOE genotype and an Alzheimer’s diagnosis.
Read the full article at Longevity Docs News ↗

Continue exploring

Recommended MoL Picks

MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.